Multimodality therapy for limited-stage small-cell lung cancer

Daniel Almquist, Kailash Mosalpuria, Apar Kishor P Ganti

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been themainstay of therapy for this condition, butmore recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.

Original languageEnglish (US)
Pages (from-to)111-117
Number of pages7
JournalJournal of oncology practice
Volume12
Issue number2
DOIs
StatePublished - Feb 2016

Fingerprint

Small Cell Lung Carcinoma
Cranial Irradiation
Combined Modality Therapy
Radiotherapy
Therapeutics
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Multimodality therapy for limited-stage small-cell lung cancer. / Almquist, Daniel; Mosalpuria, Kailash; Ganti, Apar Kishor P.

In: Journal of oncology practice, Vol. 12, No. 2, 02.2016, p. 111-117.

Research output: Contribution to journalReview article

Almquist, Daniel ; Mosalpuria, Kailash ; Ganti, Apar Kishor P. / Multimodality therapy for limited-stage small-cell lung cancer. In: Journal of oncology practice. 2016 ; Vol. 12, No. 2. pp. 111-117.
@article{9f2de9efed2e4c01ad598d25da031463,
title = "Multimodality therapy for limited-stage small-cell lung cancer",
abstract = "Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been themainstay of therapy for this condition, butmore recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.",
author = "Daniel Almquist and Kailash Mosalpuria and Ganti, {Apar Kishor P}",
year = "2016",
month = "2",
doi = "10.1200/JOP.2015.009068",
language = "English (US)",
volume = "12",
pages = "111--117",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "2",

}

TY - JOUR

T1 - Multimodality therapy for limited-stage small-cell lung cancer

AU - Almquist, Daniel

AU - Mosalpuria, Kailash

AU - Ganti, Apar Kishor P

PY - 2016/2

Y1 - 2016/2

N2 - Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been themainstay of therapy for this condition, butmore recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.

AB - Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been themainstay of therapy for this condition, butmore recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.

UR - http://www.scopus.com/inward/record.url?scp=84958243096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958243096&partnerID=8YFLogxK

U2 - 10.1200/JOP.2015.009068

DO - 10.1200/JOP.2015.009068

M3 - Review article

C2 - 26869647

AN - SCOPUS:84958243096

VL - 12

SP - 111

EP - 117

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 2

ER -